[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361456-105":59,"doc-detail-361456-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","reciprocal-signaling-metabolic-crosstalk-between-fibroblasts-and-tumor-cells-drives-cetuximab-tolerance-in-head-and-neck-cancers","Reciprocal signaling-metabolic crosstalk between fibroblasts and tumor cells drives cetuximab tolerance in head and neck cancers","","Cetuximab resistance in head and neck squamous cell carcinoma involves lipid metabolism reprogramming, TGFβ signaling, and cancer-associated fibroblast activation, yet their mechanistic convergence is unclear. Researchers used transcriptomic, metabolic, biochemical, and co-culture approaches with patient-derived fibroblasts, organoids, and xenografts. Cetuximab induced TGF-β2, coordinating tumor metabolic rewiring and fibroblast myofibroblastic, lipid-secreting states. TGFβ2-activated CAFs supplied fatty acids that sustained oxidative metabolism and preserved EGFR/MAPK signaling in a reversible drug-tolerant state.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/reciprocal-signaling-metabolic-crosstalk-between-fibroblasts-and-tumor-cells-drives-cetuximab-tolerance-in-head-and-neck-cancers/361456/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/reciprocal-signaling-metabolic-crosstalk-between-fibroblasts-and-tumor-cells-drives-cetuximab-tolerance-in-head-and-neck-cancers/361456.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does cetuximab treatment influence TGF-β2 signaling in HNSCC cells?","Question",{"text":113,"@type":114},"Cetuximab-treated HNSCC cells specifically upregulate and secrete TGF-β2. This drives coordinated adaptive programs in both tumor cells and fibroblasts.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What adaptive programs are induced by TGF-β2 during cetuximab tolerance?",{"text":118,"@type":114},"TGF-β2 promotes (i) autocrine metabolic rewiring in tumor cells to enhance fatty-acid uptake, oxidation, and storage, and (ii) paracrine activation of fibroblasts into a myofibroblastic, lipid-secreting phenotype.",{"name":120,"@type":111,"acceptedAnswer":121},"What happens when TGF-β2 signaling or fatty acid transfer is disrupted?",{"text":122,"@type":114},"Genetic or pharmacologic inhibition of TGF-β2 signaling or FA transfer abrogates the circuit and restores cetuximab sensitivity in HNSCC cells, spheroids, and patient-derived organoids. In PDX models, TGF-β2 inhibition delays tumor regrowth after treatment.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},361456,1790211113,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Vigneron et al. Journal of Experimental & Clinical Cancer Research (2026) 45:193 [https://doi.org/10.1186/s13046-026-03765-9](https://doi.org/10.1186/s13046-026-03765-9)  \nJournal of Experimental & Clinical Cancer Research  \nRESEARCH Open Access  \nReciprocal signaling-metabolic crosstalk  between fibroblasts and tumor cells drives cetuximab tolerance in head and neck cancers  \nEngy Vigneron1†, Julie Vignau1†, Olivier Lowyck2,3, Valentin Van den bossche 1,3, Jérôme Ambroise4, Yann Kieffer5, Fatima Mechta-Grigoriou5, Isabella Rizzi 1, Maria Virginia Giolito1, Manon Desgres 1, Hannah Zaryouh6, An Wouters6, Antonella Mendola2, Hajar Dahou2, Marine Leclerc1, Romain Boidot7, Aurélien Warnant8, Yvan Larondelle8, Olivier Feron1,9, Jean-Pascal Machiels2,3, Sandra Schmitz2,3† and Cyril Corbet1,9*†  \nAbstract  \nBackground Resistance to EGFR-targeted therapies, including cetuximab, remains a major barrier to effective treatment of head and neck squamous cell carcinoma (HNSCC) . Lipid metabolism reprogramming, TGFβ signaling, and cancer-associated fibroblast (CAF) activation have each been linked to cetuximab resistance, but how these processes mechanistically converge remains unclear.  \nMethods We integrated transcriptomic, metabolic, and biochemical assays in HNSCC cell lines, co-culture systems with matched patient-derived non tumoral fibroblasts and CAFs, patient-derived organoids (PDOs), and patientderived xenografts (PDXs) to characterize tumor-stroma interactions during cetuximab treatment. Fluorescencebased fatty acid (FA) tracing and lipidomic analyses were used to assess FA flux. Functional relevance was tested through genetic and pharmacologic inhibition ofTGF-β2 signaling and FA transfer. Clinical relevance was assessed by analyzing TGFB2 expression and plasma TGF-β2 levels in HNSCC patient cohorts.  \nResults Cetuximab-treated HNSCC cells specifically upregulated and secretedTGF-β2, which induced two coordinated adaptive programs: (i) autocrine metabolic rewiring promoting FA uptake, oxidation, and storage in tumor cells, and (ii) paracrine activation of fibroblasts toward a myofibroblastic, lipid-secreting phenotype. These TGFβ2-activated CAFs supplied FA that sustained oxidative metabolism and preserved EGFR/MAPK signaling in tumor cells, establishing a reciprocal feedback loop that maintained a reversible drug-tolerant state. Disrupting either TGF-β2 signaling or FA transfer abrogated this circuit and restored cetuximab sensitivity in HNSCC cells, spheroids, and PDOs. In PDX models, TGF-β2 inhibition delayed tumor regrowth following cetuximab treatment. Elevated TGFB2 expression  \n\n| †Engy Vigneron and Julie Vignau have equally contributed to this work. |\n| --- |\n| †Sandra Schmitz and Cyril Corbet have equally supervised this work. |\n\n*Correspondence: Cyril Corbet  \ncyril.corbet@uclouvain.be  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The)[. The](http://creativecommons.org/licenses/by/4.0/. The)[ ](http://creativecommons.org/licenses/by/4.0/. The)Creative Commons Public Domain Dedication waive","cbCailupN6OtqEfB","https://ap.wps.com/l/cbCailupN6OtqEfB","pdf",9397704,22,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Cetuximab and resistance in HNSCC\n## Clinical context and rationale for studying drug-tolerant cells","[{\"question\":\"How does cetuximab treatment influence TGF-β2 signaling in HNSCC cells?\",\"answer\":\"Cetuximab-treated HNSCC cells specifically upregulate and secrete TGF-β2. This drives coordinated adaptive programs in both tumor cells and fibroblasts.\"},{\"question\":\"What adaptive programs are induced by TGF-β2 during cetuximab tolerance?\",\"answer\":\"TGF-β2 promotes (i) autocrine metabolic rewiring in tumor cells to enhance fatty-acid uptake, oxidation, and storage, and (ii) paracrine activation of fibroblasts into a myofibroblastic, lipid-secreting phenotype.\"},{\"question\":\"What happens when TGF-β2 signaling or fatty acid transfer is disrupted?\",\"answer\":\"Genetic or pharmacologic inhibition of TGF-β2 signaling or FA transfer abrogates the circuit and restores cetuximab sensitivity in HNSCC cells, spheroids, and patient-derived organoids. In PDX models, TGF-β2 inhibition delays tumor regrowth after treatment.\"}]","Reciprocal signaling-metabolic crosstalk between fibroblasts and tumor cells drives cetuximab tolerance in head and neck cancers | PDF",1790144381,55,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71089ce447d3a241813c5b58ed913d3f.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edb638ef1fa65ecd0256cc8114e46054.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd08a386da243f3ff3234300a0f63e16.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d074ef0fb33e1b388761993bc208c1d.webp",980,1306]